(Q35538953)

8 August 2017

1 reference

title

Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future (English)

1 reference

head and neck squamous cell carcinoma

8 August 2017

1 reference

Sophie Marchal

1

1 reference

8 August 2017

Gilles Dolivet

2

1 reference

8 August 2017

Henri-Pierre Lassalle

3

1 reference

8 August 2017

François Guillemin

4

1 reference

8 August 2017

Lina Bezdetnaya

5

1 reference

8 August 2017

7 January 2015

1 reference

Lasers in Medical Science

8 August 2017

1 reference

8 August 2017

30

1 reference

8 August 2017

9

1 reference

8 August 2017

2381-2387

1 reference

https://scigraph.springernature.com/pub.10.1007/s10103-014-1703-4

8 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Photodynamic therapy of cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

The application and challenges of clinical PD-PDT in the head and neck region: a short review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Photodynamic therapy of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

A matched cohort comparison of mTHPC-mediated photodynamic therapy and trans-oral surgery of early stage oral cavity squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

The surgical palliation of advanced head and neck cancer using photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Photochemical internalization: a new tool for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Targeted photodynamic therapy--a promising strategy of tumor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Nanophotosensitizers toward advanced photodynamic therapy of Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

The role of epidermal growth factor receptor in photodynamic therapy: a review of the literature and proposal for future investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3: Targeting survival pathways to increase PDT efficacy in ovarian and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Liposomal nanostructures for photosensitizer delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Photodynamic therapy using an anti-EGF receptor antibody complexed with verteporfin nanoparticles: a proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

A cell-targeted photodynamic nanomedicine strategy for head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

mTHPC-mediated photodynamic treatment up-regulates the cytokines VEGF and IL-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Predictive factor for photodynamic therapy effects on oral squamous cell carcinoma and oral epithelial dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Development and applications of photo-triggered theranostic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Vascular targeted nanoparticles for imaging and treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Nanomedicine(s) under the microscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

Adjuvant intraoperative photodynamic therapy in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10103-014-1703-4

In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy

21 January 2018

1 reference

12 December 2020

Effect of photosensitizer dose on fluence rate responses to photodynamic therapy

1 reference

12 December 2020

Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells

1 reference

12 December 2020

Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate

1 reference

12 December 2020

Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity

1 reference

12 December 2020

mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: Development of a new method

1 reference

12 December 2020

Photodynamic Therapy of Feline Cutaneous Squamous Cell Carcinoma Using a Newly Developed Liposomal Photosensitizer: Preliminary Results Concerning Drug Safety and Efficacy

1 reference

12 December 2020

10.1007/S10103-014-1703-4

Identifiers

DOI

1 reference

8 August 2017

1 reference